The Extracellular Matrix : Its Composition, Function, Remodeling, and Role in Tumorigenesis
The extracellular matrix (ECM) is a ubiquitous member of the body and is key to the maintenance of tissue and organ integrity. Initially thought to be a bystander in many cellular processes, the extracellular matrix has been shown to have diverse components that regulate and activate many cellular processes and ultimately influence cell phenotype. Importantly, the ECM's composition, architecture, and stiffness/elasticity influence cellular phenotypes. Under normal conditions and during development, the synthesized ECM constantly undergoes degradation and remodeling processes via the action of matrix proteases that maintain tissue homeostasis. In many pathological conditions including fibrosis and cancer, ECM synthesis, remodeling, and degradation is dysregulated, causing its integrity to be altered. Both physical and chemical cues from the ECM are sensed via receptors including integrins and play key roles in driving cellular proliferation and differentiation and in the progression of various diseases such as cancers. Advances in 'omics' technologies have seen an increase in studies focusing on bidirectional cell-matrix interactions, and here, we highlight the emerging knowledge on the role played by the ECM during normal development and in pathological conditions. This review summarizes current ECM-targeted therapies that can modify ECM tumors to overcome drug resistance and better cancer treatment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Biomimetics (Basel, Switzerland) - 8(2023), 2 vom: 05. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dzobo, Kevin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cell adhesion |
|---|
| Anmerkungen: |
Date Revised 19.09.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/biomimetics8020146 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355961180 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355961180 | ||
| 003 | DE-627 | ||
| 005 | 20231226065442.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/biomimetics8020146 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1186.xml |
| 035 | |a (DE-627)NLM355961180 | ||
| 035 | |a (NLM)37092398 | ||
| 035 | |a (PII)146 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dzobo, Kevin |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Extracellular Matrix |b Its Composition, Function, Remodeling, and Role in Tumorigenesis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 19.09.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a The extracellular matrix (ECM) is a ubiquitous member of the body and is key to the maintenance of tissue and organ integrity. Initially thought to be a bystander in many cellular processes, the extracellular matrix has been shown to have diverse components that regulate and activate many cellular processes and ultimately influence cell phenotype. Importantly, the ECM's composition, architecture, and stiffness/elasticity influence cellular phenotypes. Under normal conditions and during development, the synthesized ECM constantly undergoes degradation and remodeling processes via the action of matrix proteases that maintain tissue homeostasis. In many pathological conditions including fibrosis and cancer, ECM synthesis, remodeling, and degradation is dysregulated, causing its integrity to be altered. Both physical and chemical cues from the ECM are sensed via receptors including integrins and play key roles in driving cellular proliferation and differentiation and in the progression of various diseases such as cancers. Advances in 'omics' technologies have seen an increase in studies focusing on bidirectional cell-matrix interactions, and here, we highlight the emerging knowledge on the role played by the ECM during normal development and in pathological conditions. This review summarizes current ECM-targeted therapies that can modify ECM tumors to overcome drug resistance and better cancer treatment | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a cell adhesion | |
| 650 | 4 | |a collagens | |
| 650 | 4 | |a development | |
| 650 | 4 | |a extracellular matrix | |
| 650 | 4 | |a fibronectin | |
| 650 | 4 | |a integrins | |
| 650 | 4 | |a matrix metalloproteases | |
| 650 | 4 | |a metastasis | |
| 650 | 4 | |a organs | |
| 650 | 4 | |a signaling | |
| 650 | 4 | |a tissues | |
| 650 | 4 | |a tumor progression | |
| 700 | 1 | |a Dandara, Collet |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomimetics (Basel, Switzerland) |d 2017 |g 8(2023), 2 vom: 05. Apr. |w (DE-627)NLM280217293 |x 2313-7673 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2023 |g number:2 |g day:05 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/biomimetics8020146 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2023 |e 2 |b 05 |c 04 | ||